10 December 2018
Within the Armed Forces Institute of Regenerative Medicine (AFIRM), a large federally funded US institution committed to develop clinical Regenerative Medicine therapies for wounded warriors, additional funding has been assigned to the group Regenerative Biomaterials, Dept. of Dentistry.
In this institution, Regenerative Biomaterials is the only non-US partner and their research is focused on the development of an injectable and fast-degradable calciumphosphate cement for craniomaxillofacial applications related to bone defects. The additional funding (~190 USD) enables Jeroen van den Beucken and John Jansen, theme Reconstructive and regenerative medicine, to evaluate broader applications of this bone substitute material for the preservation and augmentation of alveolar bone.-
Want to know more about these subjects? Click on the buttons below for more news.